Featured Products

My Quote Request

No products added yet

6505-01-366-5017

20 Products

NDC00536-3541-01

CYANOCOBALAMIN TABLETS

NSN, MFG P/N

6505013665017

NSN

6505-01-366-5017

View More Info

NDC00536-3541-01

CYANOCOBALAMIN TABLETS

NSN, MFG P/N

6505013665017

NSN

6505-01-366-5017

MFG

RUGBY GROUP INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MICROGRAMS CYANOCOBALAMIN ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

CORGARD TABLETS

NADOLOL TABLETS,USP

NSN, MFG P/N

6505013660939

NSN

6505-01-366-0939

View More Info

CORGARD TABLETS

NADOLOL TABLETS,USP

NSN, MFG P/N

6505013660939

NSN

6505-01-366-0939

MFG

BRISTOL-MYERS SQUIBB CO WESTWOOD-SQUIBB PHARMACEUTICALS DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS NADOLOL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NADOLOL TABLETS USP 20MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD, BRISTOL-MYERS SQUIBB CO

F92I168

NADOLOL TABLETS,USP

NSN, MFG P/N

6505013660939

NSN

6505-01-366-0939

View More Info

F92I168

NADOLOL TABLETS,USP

NSN, MFG P/N

6505013660939

NSN

6505-01-366-0939

MFG

AIR FORCE MEDICAL LOGISTICS OFFICE

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS NADOLOL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NADOLOL TABLETS USP 20MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD, BRISTOL-MYERS SQUIBB CO

NDC00003-0232-50

NADOLOL TABLETS,USP

NSN, MFG P/N

6505013660939

NSN

6505-01-366-0939

View More Info

NDC00003-0232-50

NADOLOL TABLETS,USP

NSN, MFG P/N

6505013660939

NSN

6505-01-366-0939

MFG

SQUIBB E R AND SONS INC WORLD HQ

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS NADOLOL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NADOLOL TABLETS USP 20MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD, BRISTOL-MYERS SQUIBB CO

F92I233

LEVOTHYROXINE SODIUM TABLETS,USP

NSN, MFG P/N

6505013660962

NSN

6505-01-366-0962

View More Info

F92I233

LEVOTHYROXINE SODIUM TABLETS,USP

NSN, MFG P/N

6505013660962

NSN

6505-01-366-0962

MFG

AIR FORCE MEDICAL LOGISTICS OFFICE

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 MICROGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVOTHYROXINE SODIUM TABLETS USP 75MCG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

NDC00048-1050-05

LEVOTHYROXINE SODIUM TABLETS,USP

NSN, MFG P/N

6505013660962

NSN

6505-01-366-0962

View More Info

NDC00048-1050-05

LEVOTHYROXINE SODIUM TABLETS,USP

NSN, MFG P/N

6505013660962

NSN

6505-01-366-0962

MFG

BOOTS PHARMACEUTICALS INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 MICROGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVOTHYROXINE SODIUM TABLETS USP 75MCG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

NDC52604-5075-02

LEVOTHYROXINE SODIUM TABLETS,USP

NSN, MFG P/N

6505013660962

NSN

6505-01-366-0962

View More Info

NDC52604-5075-02

LEVOTHYROXINE SODIUM TABLETS,USP

NSN, MFG P/N

6505013660962

NSN

6505-01-366-0962

MFG

JONES MEDICAL INDUSTRIES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 MICROGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVOTHYROXINE SODIUM TABLETS USP 75MCG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

SYNTHROID

LEVOTHYROXINE SODIUM TABLETS,USP

NSN, MFG P/N

6505013660962

NSN

6505-01-366-0962

View More Info

SYNTHROID

LEVOTHYROXINE SODIUM TABLETS,USP

NSN, MFG P/N

6505013660962

NSN

6505-01-366-0962

MFG

BOOTS PHARMACEUTICALS INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 MICROGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVOTHYROXINE SODIUM TABLETS USP 75MCG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

SYNTHROID TABLETS

LEVOTHYROXINE SODIUM TABLETS,USP

NSN, MFG P/N

6505013660962

NSN

6505-01-366-0962

View More Info

SYNTHROID TABLETS

LEVOTHYROXINE SODIUM TABLETS,USP

NSN, MFG P/N

6505013660962

NSN

6505-01-366-0962

MFG

BOOTS PHARMACEUTICALS INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 MICROGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVOTHYROXINE SODIUM TABLETS USP 75MCG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

NDC00536-1950-78

MAGNESIA AND ALUMINA ORAL SUSPENSION,USP

NSN, MFG P/N

6505013661452

NSN

6505-01-366-1452

View More Info

NDC00536-1950-78

MAGNESIA AND ALUMINA ORAL SUSPENSION,USP

NSN, MFG P/N

6505013661452

NSN

6505-01-366-1452

MFG

RUGBY GROUP INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS MAGNESIUM HYDROXIDE PER 5 MILLILITERS AND 225.000 MILLIGRAMS ALUMINUM HYDROXIDE GEL, DRIED PER 5 MILLILITERS
ADMINISTRATION: ORAL
FLAVOR: MINT
PRIMARY CONTAINER CONTENT QUANTITY: 26.000 FLUID OUNCES OR 769.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: NON-CONSTIPATING ANTACID SUSPENSION

14602

HALOPERIDOL TABLETS,USP

NSN, MFG P/N

6505013663058

NSN

6505-01-366-3058

View More Info

14602

HALOPERIDOL TABLETS,USP

NSN, MFG P/N

6505013663058

NSN

6505-01-366-3058

MFG

GOLDLINE LABORATORIES GOVERNMENT SALES DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS HALOPERIDOL ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: EXPIRATION DATED

NDC00182-1854-05

HALOPERIDOL TABLETS,USP

NSN, MFG P/N

6505013663058

NSN

6505-01-366-3058

View More Info

NDC00182-1854-05

HALOPERIDOL TABLETS,USP

NSN, MFG P/N

6505013663058

NSN

6505-01-366-3058

MFG

GOLDLINE LABORATORIES GOVERNMENT SALES DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS HALOPERIDOL ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: EXPIRATION DATED

NDC00536-3880-05

HALOPERIDOL TABLETS,USP

NSN, MFG P/N

6505013663058

NSN

6505-01-366-3058

View More Info

NDC00536-3880-05

HALOPERIDOL TABLETS,USP

NSN, MFG P/N

6505013663058

NSN

6505-01-366-3058

MFG

RUGBY GROUP INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS HALOPERIDOL ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: EXPIRATION DATED

NDC00536-3879-05

HALOPERIDOL TABLETS,USP

NSN, MFG P/N

6505013663059

NSN

6505-01-366-3059

View More Info

NDC00536-3879-05

HALOPERIDOL TABLETS,USP

NSN, MFG P/N

6505013663059

NSN

6505-01-366-3059

MFG

RUGBY GROUP INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS HALOPERIDOL ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: EXPIRATION DATED

ACTIVASE

ALTEPLASE FOR INJECTION

NSN, MFG P/N

6505013663202

NSN

6505-01-366-3202

View More Info

ACTIVASE

ALTEPLASE FOR INJECTION

NSN, MFG P/N

6505013663202

NSN

6505-01-366-3202

MFG

GENENTECH INC.

Description

FEATURES PROVIDED: DILUENT AND STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ALTEPLASE FOR INJECTION 58000000 INTERNATIONAL UNITS
PHYSICAL FORM: FREEZE-DRIED POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 58000000.000 INTERNATIONAL UNITS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: 58 MILLION I.U. OF ALTEPLASE EQUIV. PER 100 MG; ALSO CONTAINS 3.5 GRAMS L-ARGININE,1 GRAM PHOSPHORIC ACID,AND LESS THAN 11 MG POLYSORBATE 80; RECOMBINANT; W/ONE 100 ML VIAL OF STERILE WATER FOR INJECTION,USP AND ONE TRANSFER DEVICE; FOR USE AS A
TOTAL PRIMARY CONTAINER QUANTITY: 1
~1: THROMBOLYTIC AGENT

NDC50242-0085-27

ALTEPLASE FOR INJECTION

NSN, MFG P/N

6505013663202

NSN

6505-01-366-3202

View More Info

NDC50242-0085-27

ALTEPLASE FOR INJECTION

NSN, MFG P/N

6505013663202

NSN

6505-01-366-3202

MFG

GENENTECH INC.

Description

FEATURES PROVIDED: DILUENT AND STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ALTEPLASE FOR INJECTION 58000000 INTERNATIONAL UNITS
PHYSICAL FORM: FREEZE-DRIED POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 58000000.000 INTERNATIONAL UNITS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: 58 MILLION I.U. OF ALTEPLASE EQUIV. PER 100 MG; ALSO CONTAINS 3.5 GRAMS L-ARGININE,1 GRAM PHOSPHORIC ACID,AND LESS THAN 11 MG POLYSORBATE 80; RECOMBINANT; W/ONE 100 ML VIAL OF STERILE WATER FOR INJECTION,USP AND ONE TRANSFER DEVICE; FOR USE AS A
TOTAL PRIMARY CONTAINER QUANTITY: 1
~1: THROMBOLYTIC AGENT

NDC12496-0757-01

BUPRENORPHINE HYDROCHLORIDE INJECTION

NSN, MFG P/N

6505013664754

NSN

6505-01-366-4754

View More Info

NDC12496-0757-01

BUPRENORPHINE HYDROCHLORIDE INJECTION

NSN, MFG P/N

6505013664754

NSN

6505-01-366-4754

MFG

RECKITT AND COLMAN PHARMACEUTICAL INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.300 MILLIGRAMS BUPRENORPHINE EQUIVALENT
III CONTROLLED SUBSTANCE CLASSIFICATION: SCHEDULE V
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BUPRENORPHINE HYDROCHLORIDE INJECTION 0.3MG AMPUL 10S
III PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 10

B9747

PERITONEAL DIALYSIS SOLUTION

NSN, MFG P/N

6505013665009

NSN

6505-01-366-5009

View More Info

B9747

PERITONEAL DIALYSIS SOLUTION

NSN, MFG P/N

6505013665009

NSN

6505-01-366-5009

MFG

BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.250 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 132.000 MILLIEQUIVALENTS SODIUM ION PER LITER AND 2.500 MILLIEQUIVALENTS CALCIUM ION PER LITER AND 95.000 MILLIEQUIVALENTS CHLORIDE ION PER LITER AND 0.5 MILLIEQUIVALENT MAGNESIUM ION PER LITER AND 40
PRIMARY CONTAINER CONTENT QUANTITY: 2000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 6
~1: MILLIEQUIVALENT LACTATE ION PER LITER

5B9727

PERITONEAL DIALYSIS SOLUTION

NSN, MFG P/N

6505013665010

NSN

6505-01-366-5010

View More Info

5B9727

PERITONEAL DIALYSIS SOLUTION

NSN, MFG P/N

6505013665010

NSN

6505-01-366-5010

MFG

BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 132.000 MILLIEQUIVALENTS SODIUM ION PER LITER AND 2.500 MILLIEQUIVALENTS CALCIUM ION PER LITER AND 95.000 MILLIEQUIVALENTS CHLORIDE ION PER LITER AND 0.5 MILLIEQUIVALENT MAGNESIUM ION PER LITER AND 40
PRIMARY CONTAINER CONTENT QUANTITY: 2000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 6
~1: MILLIEQUIVALENT LACTATE ION PER LITER

044-20204

PERITONEAL DIALYSIS SOLUTION

NSN, MFG P/N

6505013665011

NSN

6505-01-366-5011

View More Info

044-20204

PERITONEAL DIALYSIS SOLUTION

NSN, MFG P/N

6505013665011

NSN

6505-01-366-5011

MFG

FRESENIUS USA INC.

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.250 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 132.000 MILLIEQUIVALENTS SODIUM ION PER LITER AND 3.500 MILLIEQUIVALENTS CALCIUM ION PER LITER AND 96.000 MILLIEQUIVALENTS CHLORIDE ION PER LITER AND 0.5 MILLIEQUIVALENT MAGNESIUM ION PER LITER AND 40
PRIMARY CONTAINER CONTENT QUANTITY: 2000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 6
~1: MILLIEQUIVALENT LACTATE ION PER LITER